Maxeema Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.20 Cr
as on 16-11-2024
- Revenue -12.59%
(FY 2023)
- Profit -10.28%
(FY 2023)
- Ebitda -43.34%
(FY 2023)
- Net Worth -1.38%
(FY 2023)
- Total Assets 27.46%
(FY 2023)
About Maxeema Bio-Tech
The Corporate was formerly known as Nexus Bio-Tech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹5.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Chaudhari, Kandarp Bakshi, Chaitanya Shroff, and One other member serve as directors at the Company.
- CIN/LLPIN
U24117GJ2000PTC038773
- Company No.
038773
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2000
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maxeema Bio-Tech Private Limited offer?
Maxeema Bio-Tech Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Selective Herbicide, Termiticide, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Essential & Aromatic Oils, Carrier Oil, Acaricide, Larvicide, Non Selective Herbicide.
Who are the key members and board of directors at Maxeema Bio-Tech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandarp Bakshi  | Managing Director | 11-Oct-2000 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendra Chaudhari | Additional Director | 10-Jan-2024 | Current |
| Chaitanya Shroff | Director | Current | |
| Arunkumar Dhuri | Additional Director | 10-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Maxeema Bio-Tech.
Maxeema Bio-Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.59% decrease. The company also saw a substantial fall in profitability, with a 10.28% decrease in profit. The company's net worth dipped by a decrease of 1.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxeema Bio-Tech?
In 2023, Maxeema Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vantage Chemical Industries Private LimitedActive 4 years 8 monthsChaitanya Shroff is a mutual person
- Dipkanti Investments And Financing Private LimitedActive 40 years 6 months
Chaitanya Shroff is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Apr 2024 | ₹5.00 Cr | Open |
Others Creation Date: 01 Apr 2024 | ₹3.00 Cr | Open |
Others Creation Date: 01 Jul 2019 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Maxeema Bio-Tech?
Maxeema Bio-Tech has a workforce of 9 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxeema Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxeema Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
